RAS testing of colorectal carcinoma—a guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Group
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RAS testing of colorectal carcinoma—a guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Group
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PATHOLOGY
Volume 67, Issue 9, Pages 751-757
Publisher
BMJ
Online
2014-07-05
DOI
10.1136/jclinpath-2014-202467
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intra-tumoral Heterogeneity ofKRASandBRAFMutation Status in Patients with Advanced Colorectal Cancer (aCRC) and Cost-Effectiveness of Multiple Sample Testing
- (2015) Susan D. Richman et al. Analytical Cellular Pathology
- Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
- (2014) Alain R Thierry et al. NATURE MEDICINE
- KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs and beyond
- (2013) Umberto Malapelle et al. JOURNAL OF CLINICAL PATHOLOGY
- Unknown
- (2013) Mariella Dono et al. MOLECULAR MEDICINE
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of COBAS 4800 KRAS, TaqMan PCR and High Resolution Melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomas
- (2013) Alexandre Harlé et al. VIRCHOWS ARCHIV
- Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
- (2012) Mi-Jung Kim et al. BMC CANCER
- A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens
- (2012) D Gonzalez de Castro et al. BRITISH JOURNAL OF CANCER
- Concordant KRAS Mutations in Primary and Metastatic Colorectal Cancer Tissue Specimens: A Meta-Analysis and Systematic Review
- (2012) Cheng-Bo Han et al. CANCER INVESTIGATION
- Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM)
- (2012) Pilar García-Alfonso et al. Clinical & Translational Oncology
- The utility of diagnostic biopsy specimens for predictive molecular testing in colorectal cancer
- (2012) Wakkas Fadhil et al. HISTOPATHOLOGY
- Hurdles and Complexities of Codon 13 KRAS Mutations
- (2012) Maria Pia Morelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study
- (2011) C. Bokemeyer et al. ANNALS OF ONCOLOGY
- Validation of KRAS Testing for Anti-EGFR Therapeutic Decisions for Patients With Metastatic Colorectal Carcinoma
- (2011) Suzanne Kamel-Reid et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- KRAS mutations detected by the amplification refractory mutation system–Scorpion assays strongly correlate with therapeutic effect of cetuximab
- (2011) H Bando et al. BRITISH JOURNAL OF CANCER
- Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer
- (2011) Ben Tran et al. CANCER
- Dynamics of cancer cell subpopulations in primary and metastatic colorectal tumors
- (2011) Teodora Evgenieva Goranova et al. CLINICAL & EXPERIMENTAL METASTASIS
- Increased Detection Sensitivity for KRAS Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer
- (2011) F. Molinari et al. CLINICAL CANCER RESEARCH
- Molecular Genetics External Quality Assessment Pilot Scheme for KRAS Analysis in Metastatic Colorectal Cancer
- (2011) Zandra C. Deans et al. Genetic Testing and Molecular Biomarkers
- Preparing pathology for personalized medicine: possibilities for improvement of the pre-analytical phase
- (2011) Patricia J T A Groenen et al. HISTOPATHOLOGY
- Should Oncologists Be Aware in Their Clinical Practice ofKRASMolecular Analysis?
- (2011) Daniele Santini et al. JOURNAL OF CLINICAL ONCOLOGY
- KRAS Mutations Testing in Colorectal Carcinoma Patients in Italy: From Guidelines to External Quality Assessment
- (2011) Nicola Normanno et al. PLoS One
- Prevalence and Heterogeneity of KRAS, BRAF, and PIK3CA Mutations in Primary Colorectal Adenocarcinomas and Their Corresponding Metastases
- (2010) S. E. Baldus et al. CLINICAL CANCER RESEARCH
- KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma
- (2010) N. K. B. Pang et al. CYTOPATHOLOGY
- A standardized framework for the validation and verification of clinical molecular genetic tests
- (2010) Christopher J Mattocks et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- A Multicenter Blinded Study to Evaluate KRAS Mutation Testing Methodologies in the Clinical Setting
- (2009) Vicki Whitehall et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Effects of Tissue Fixation Alternatives on DNA Content
- (2008) Gulcan Baloglu et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started